Accessibility Menu
PAVmed Stock Quote

PAVmed (NASDAQ: PAVM)

$0.43
(-9.6%)
-0.05
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$0.43
Daily Change
(-9.6%) $0.05
Day's Range
$0.4 - $0.48
Previous Close
$0.43
Open
$0.46
Beta
1.36
Volume
939,485
Average Volume
358,679
Market Cap
9.4M
Market Cap / Employee
$0.43M
52wk Range
$0.3 - $1.25
Revenue
-
Gross Margin
-0.84%
Dividend Yield
N/A
EPS
$1.16
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

PAVmed Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
PAVM-59.81%-98.27%-55.58%-100%
S&P+15.06%+95.03%+14.29%+210%

PAVmed Company Info

PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. Its products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. The company was founded on June 26, 2014 and is headquartered in New York, NY.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.01M-99.4%
Gross Profit-$0.06M94.3%
Gross Margin-950.00%-848.7%
Market Cap$10.38M35.1%
Market Cap / Employee$0.27M0.0%
Employees39-63.6%
Net Income-$12.32M17.4%
EBITDA-$4.69M64.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$4.00M-84.3%
Accounts Receivable$0.00M-98.6%
Inventory0-100.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$1.97M-57.8%
Short Term Debt$7.34M-83.8%

Ratios

Q2 2025YOY Change
Return On Assets174.96%299.0%
Return On Invested Capital-3016.89%-3295.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$1.19M89.8%
Operating Free Cash Flow-$1.18M89.9%

Valuation

MetricQ1 2025Q2 2025YoY Change
Price to Earnings1.020.52-
Price to Book-0.15-0.83-1.390.54-635.22%
Price to Sales13.562.3519.0010.64446.33%
Price to Tangible Book Value-0.15-0.83-1.390.54-643.33%
Enterprise Value to EBITDA-7.72-7.13-12.33-7.389.12%
Total Debt$34.93M$31.86M$9.24M$9.31M-81.39%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.